* Medifast Inc MED.N MED is expected to show a rise in
quarterly revenue when it reports results on May 2.
* The Owings Mills Maryland-based company is expected to
report
a 18.4% increase in revenue to $403.253 million from $340.67
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $3.57 per share. For the same quarter last year, the
company reported earnings of $3.46 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 3.6%
in the last three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$341, above its last closing price of $178.36.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 2.65 2.65 2.91 Beat 9.7
Sep. 30 2021 3.09 3.08 3.56 Beat 15.6
Jun. 30 2021 3.36 3.32 3.96 Beat 19.4
Mar. 31 2021 2.74 2.73 3.46 Beat 26.9
Dec. 2.37 2.38 2.36 Missed -0.8
31 2020
Sep. 30 2020 2.54 2.46 2.91 Beat 18.5
Jun. 30 2020 1.84 1.83 1.96 Beat 7
Mar. 31 2020 1.31 1.33 1.93 Beat 45.4
This summary was machine generated April 30 at 02:07 GMT. All
figures in US dollars unless otherwise stated